Premature Ejaculation Treatment Market - Global Forecast, 2022 - 2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	190 Pages	Coherent Market Insights	May, 2022	CMI17211341

Best Price Guarantee
Price	from $4,500
Length	190 Pages
Publisher	Coherent Market Insights
Published Date	May, 2022
SKU	CMI17211341

Premature Ejaculation Treatment Market - Global Forecast, 2022 - 2028

Premature ejaculation also called as rapid ejaculation, premature climax or early ejaculation. It is a disorder, which causes early ejaculation of semen during sexual intercourse. Premature ejaculation is a very common problem, and its exact cause is not known. However, causes include early sexual experiences, sexual abuse, poor body image, depression, anxiety, abnormal hormone levels, inherited traits, inflammation and infection of the prostate or urethra, and worrying about premature ejaculation.
Market Dynamics
Increasing launches of novel products for the treatment of premature ejaculation is expected to fuel the global premature ejaculation treatment market growth. For instance, in 2016, Regent Pacific Group Limited, a Hong Kong-based investment group, launched its product, Fortacin in the U.K. Fortacin is a topical spray, which contains low doses of two anesthetics - lidocaine and prilocaine and is indicated for the treatment of premature ejaculation. Furthermore, increasing prevalence of premature ejaculation due to unhealthy lifestyle and various factors such as depression and hormonal imbalance is expected to rise demand for premature ejaculation treatment drugs. For instance, according to the data published by National Center for BioDrug Type Information in 2016, around 25.8% of male in China are suffering from premature ejaculation.
Key features of the study:

This report provides in-depth analysis of premature ejaculation treatment market and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global premature ejaculation treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
Key companies covered as a part of this study include Regent Pacific Group Limited, Menarini Group, Furiex Pharmaceuticals, Inc., Absorption Pharmaceuticals, LLC, Ampio Pharmaceuticals, Inc., Aytu BioScience, NeuroHealing Pharmaceuticals Inc., and Dong-A Pharmaceutical Co., Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technological up-gradation, market expansion, and marketing tactics
The global premature ejaculation treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the premature ejaculation treatment market

Detailed Segmentation:

Global Premature Ejaculation Treatment Market, By Drug Type :

Selective Serotonin Reuptake Inhibitors (SSRIs)

Dapoxetine
Others

Phosphodiesterase Type 5 (PDE5) Inhibitors

Zertane
Others

Topical Anesthetics
Others

Global Premature Ejaculation Treatment Market, By Route of Administration:

Oral
Topical

Global Premature Ejaculation Treatment Market, By Dosage Form:

Pills
Spray
Others

Global Premature Ejaculation Treatment Market, By Distribution Channel:

Hospitals
Online Pharmacies
Retail Pharmacies

Global Premature Ejaculation Treatment Market, By Geography:

North America

Drug Type:

Selective Serotonin Reuptake Inhibitors (SSRIs)

Dapoxetine
Others

Phosphodiesterase Type 5 (PDE5) Inhibitors

Zertane
Others

Topical Anesthetics
Others

By Route of Administration:

Oral
Topical

By Dosage Form

Pills
Spray
Others

By Distribution Channel

Hospitals
Online Pharmacies
Retail Pharmacies

By Country:

U.S.
Canada

Europe

Drug Type:

Selective Serotonin Reuptake Inhibitors (SSRIs)

Dapoxetine
Others

Phosphodiesterase Type 5 (PDE5) Inhibitors

Zertane
Others

Topical Anesthetics
Others

By Route of Administration:

Oral
Topical

By Dosage Form

Pills
Spray
Others

By Distribution Channel

Hospitals
Online Pharmacies
Retail Pharmacies

By Country:

U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe

Asia Pacific

Drug Type:

Selective Serotonin Reuptake Inhibitors (SSRIs)

Dapoxetine
Others

Phosphodiesterase Type 5 (PDE5) Inhibitors

Zertane
Others

Topical Anesthetics
Others

By Route of Administration:

Oral
Topical

By Dosage Form

Pills
Spray
Others

By Distribution Channel

Hospitals
Online Pharmacies
Retail Pharmacies

By Country:

China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific

Latin America

Drug Type:

Selective Serotonin Reuptake Inhibitors (SSRIs)

Dapoxetine
Others

Phosphodiesterase Type 5 (PDE5) Inhibitors

Zertane
Others

Topical Anesthetics
Others

By Route of Administration:

Oral
Topical

By Dosage Form

Pills
Spray
Others

By Distribution Channel

Hospitals
Online Pharmacies
Retail Pharmacies

By Country:

Brazil
Mexico
Argentina
Rest of Latin America

Middle East

Drug Type:

Selective Serotonin Reuptake Inhibitors (SSRIs)

Dapoxetine
Others

Phosphodiesterase Type 5 (PDE5) Inhibitors

Zertane
Others

Topical Anesthetics
Others

By Route of Administration:

Oral
Topical

By Dosage Form

Pills
Spray
Others

By Distribution Channel

Hospitals
Online Pharmacies
Retail Pharmacies

By Country:

GCC
Israel
Rest of Middle East

Africa

Drug Type:

Selective Serotonin Reuptake Inhibitors (SSRIs)

Dapoxetine
Others

Phosphodiesterase Type 5 (PDE5) Inhibitors

Zertane
Others

Topical Anesthetics
Others

By Route of Administration:

Oral
Topical

By Dosage Form

Pills
Spray
Others

By Distribution Channel

Hospitals
Online Pharmacies
Retail Pharmacies

By Country:

Central Africa
South Africa
North Africa

Company Profiles

Regent Pacific Group Limited *

Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments

Menarini Group
Furiex Pharmaceuticals, Inc.
Absorption Pharmaceuticals, LLC
Ampio Pharmaceuticals, Inc.
Aytu BioScience
NeuroHealing Pharmaceuticals Inc.
Dong-A Pharmaceutical Co., Ltd.

“*” marked represents similar segmentation in other categories in the respective section.

1. Research Objective and Assumption: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snippet, By Drug Type; Market Snippet, By Route of Administration; Market Snippet, By Dosage Form; Market Snippet, By Distribution Channel; Market Snippet, By Region; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Drivers; Restraints; Market Opportunities; PEST Analysis; Pipeline Analysis; Product Approval; Product Launch; Collaboration-Acquisition; Porter’s Five Forces Analysis
4. Global Premature Ejaculation Treatment Market, By Drug Type, 2017 - 2028 (US$ Bn): Introduction; Market Share Analysis, 2022 and 2028 (%); Y-o-Y Growth Analysis, 2017 - 2028; Segment Trends; Selective Serotonin Reuptake Inhibitors (SSRIs); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn); Segment Trends; Dapoxetine; Others; Phosphodiesterase Type 5 (PDE5) Inhibitors; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn); Segment Trends; Zertane; Others; Topical Anesthetics; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn); Others; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
5. Global Premature Ejaculation Treatment Market, By Route of Administration, 2017 - 2028 (US$ Bn): Introduction; Market Share Analysis, 2022 and 2028 (%); Y-o-Y Growth Analysis, 2017 - 2028; Segment Trends; Oral; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn); Topical; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
6. Global Premature Ejaculation Treatment Market, Dosage Form, 2017 - 2028 (US$ Bn): Introduction; Market Share Analysis, 2022 and 2028 (%); Y-o-Y Growth Analysis, 2017 - 2028; Segment Trends; Pills; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn); Spray; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn); Others; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
7. Global Premature Ejaculation Treatment Market, By Distribution Channel, 2017 - 2028 (US$ Bn): Introduction; Market Share Analysis, 2022 and 2028 (%); Y-o-Y Growth Analysis, 2017 - 2028; Segment Trends; Hospitals; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn); Online Pharmacies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn); Retail Pharmacies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
8. Global Premature Ejaculation Treatment Market, By Region, 2017 - 2028 (US$ Bn): Introduction; Market Share Analysis, By Region, 2022 and 2028 (%); Y-o-Y Growth Analysis, For Regions, 2017 - 2028; North America; Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Bn); Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Bn); Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Bn); Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Bn); Market Size and Forecast, By Country, 2017 - 2028 (US$ Bn); U.S.; Canada; Europe; Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Bn); Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Bn); Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Bn); Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Bn); Market Size and Forecast, By Country, 2017 - 2028 (US$ Bn); U.K.; Germany; Italy; France; Spain; Russia; Rest of Europe; Asia Pacific; Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Bn); Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Bn); Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Bn); Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Bn); Market Size and Forecast, By Country, 2017 - 2028 (US$ Bn); China; India; Japan; ASEAN; Australia; South Korea; Rest of Asia Pacific; Latin America; Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Bn); Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Bn); Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Bn); Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Bn); Market Size and Forecast, By Country, 2017 - 2028 (US$ Bn); Brazil; Mexico; Argentina; Rest of Latin America; Africa; Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Bn); Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Bn); Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Bn); Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Bn); Market Size and Forecast, By Country, 2017 - 2028 (US$ Bn); Central Africa; South Africa; North Africa; Middle East; Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Bn); Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Bn); Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Bn); Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Bn); Market Size and Forecast, By Country, 2017 - 2028 (US$ Bn); GCC; Israel; Rest of Middle East
9. Competitive Landscape: Heat Map Analysis; Company Profiles; Regent Pacific Group Limited; Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; Menarini Group; Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; Furiex Pharmaceuticals, Inc.; Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; Absorption Pharmaceuticals, LLC; Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; Ampio Pharmaceuticals, Inc.; Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; Aytu BioScience; Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; NeuroHealing Pharmaceuticals Inc.; Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; Dong-A Pharmaceutical Co., Ltd.; Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies
10. Section: References; Research Methodology; About us and Sales Contact; *Browse 37 market data tables and 40 figures on “Premature Ejaculation Treatment Market - Global forecast to 2028”.